Number | Frequency (%)/median (IQR) | |
---|---|---|
Age (years) | 45 | 14.9 (12.7–16.5) |
Sex-male | 45 | 29 (64.4%) |
HLA-B27+ | 39 | 25 (64.1%) |
Race | 39 | |
Caucasian | 32 (82.1%) | |
African American | 5 (12.8%) | |
Other | 2 (5.1%) | |
Active joint count | 36 | 0 (0–1) |
Tender enthesis count | 36 | 0 (0–5) |
Patient-reported paina (VAS; range 0–10) | 32 | 3.8 (1–6) |
Patient-reported disease activity (VAS; range 0–10) | 31 | 3 (0.5–5.1) |
Physician global disease activity (VAS; range 0–10) | 31 | 3 (2–4) |
CRP (≥1.0 mg/dL) | 28 | 17 (60.7%) |
ESR (≥21 mm/h) | 29 | 12 (41.4%) |